Variant report
Variant | esv33910 |
---|---|
Chromosome Location | chr15:34987902-34990969 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr15:34988822..34991429-chr15:34996883..34999400,2 | K562 | blood: | |
2 | chr15:34983650..34987842-chr15:34989482..34992979,5 | K562 | blood: | |
3 | chr15:34989332..34992979-chr15:34995533..34998034,4 | K562 | blood: | |
4 | chr15:34949722..34952645-chr15:34986997..34989606,2 | K562 | blood: | |
5 | chr15:34983650..34987345-chr15:34990001..34992979,4 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AC114546.1-12 | chr15:34988228-34988460 | NONHSAT041602 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149666287 | chr15:34987905-34987906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6495710 | chr15:34987914-34987915 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs567301813 | chr15:34987928-34987929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs4924131 | chr15:34987991-34987992 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs556584847 | chr15:34988034-34988035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538941509 | chr15:34988119-34988120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551970194 | chr15:34988170-34988171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs16959507 | chr15:34988200-34988201 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs531266257 | chr15:34988223-34988224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554060327 | chr15:34988299-34988300 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs188786933 | chr15:34988343-34988344 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs148582054 | chr15:34988374-34988375 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs142958323 | chr15:34988395-34988396 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs80316786 | chr15:34988441-34988442 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs147725213 | chr15:34988492-34988493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs142490865 | chr15:34988574-34988575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1469893 | chr15:34988664-34988665 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs146636452 | chr15:34988686-34988687 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192829349 | chr15:34988730-34988731 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555368220 | chr15:34988802-34988803 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573582776 | chr15:34988815-34988816 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540628219 | chr15:34988862-34988863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183349563 | chr15:34988874-34988875 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs111300364 | chr15:34988875-34988876 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545102263 | chr15:34988916-34988917 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563913135 | chr15:34988929-34988930 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531125157 | chr15:34988968-34988969 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11857049 | chr15:34989053-34989054 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs62006096 | chr15:34989077-34989078 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs62006097 | chr15:34989081-34989082 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs140459740 | chr15:34989087-34989088 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs540515520 | chr15:34989090-34989091 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186835445 | chr15:34989092-34989093 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs550648883 | chr15:34989152-34989153 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs78516697 | chr15:34989172-34989173 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs376792983 | chr15:34989299-34989300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs552131993 | chr15:34989361-34989362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536800511 | chr15:34989379-34989380 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs150398350 | chr15:34989386-34989387 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs369293924 | chr15:34989493-34989494 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528861610 | chr15:34989504-34989505 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191312180 | chr15:34989511-34989512 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs11073058 | chr15:34989626-34989627 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
44 | rs368922669 | chr15:34989628-34989629 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577703217 | chr15:34989629-34989630 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545171316 | chr15:34989662-34989663 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183762688 | chr15:34989669-34989670 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs11073059 | chr15:34989674-34989675 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs138121601 | chr15:34989701-34989702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs376827570 | chr15:34989707-34989708 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
HDAC8 | 0 | CNVD |
NIPBL | 0 | CNVD |
RAD21 | 0 | CNVD |
SMC1A | 0 | CNVD |
SMC3 | 0 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Angelman syndrome | 16183798 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21785460 | CNVD |
Abnormal corpus callosum | 21572526 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Autism | 19204725 | CNVD |
Schizophrenia | 19204725 | CNVD |
Schizophrenia | 19149910 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Legius syndrome | 19443465 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prader-willi syndrome | 21504564 | CNVD |
Cancer | 17440070 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:34985800-34989000 | Weak transcription | K562 | blood |
2 | chr15:34986200-34991600 | Weak transcription | HUVEC | blood vessel |
3 | chr15:34988600-34989600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr15:34988600-34989800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr15:34988800-34989000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr15:34988800-34989800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr15:34989000-34990200 | Enhancers | K562 | blood |
8 | chr15:34989000-34993800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr15:34989200-34989800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr15:34989200-34990000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr15:34989200-34990000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr15:34989400-34989800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
13 | chr15:34989600-34993800 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
14 | chr15:34989800-34993800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr15:34990000-34993800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
16 | chr15:34990200-34992600 | Weak transcription | K562 | blood |